Gilead elevates sales overview to consist of COVID-19 therapy remdesivir

0
1
Loading ....

By Deena Beasley and also Michael Erman
( Reuters) – Gilead Sciences Inc on Thursday published worse-than-expected quarterly outcomes, yet increased its 2020 sales projection to consist of earnings from its antiviral …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here